{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T01:56:24Z","timestamp":1775786184515,"version":"3.50.1"},"reference-count":128,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1016\/s0168-8278(01)00130-1","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T03:23:24Z","timestamp":1034306604000},"page":"421-430","source":"Crossref","is-referenced-by-count":3395,"title":["Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference"],"prefix":"10.1016","volume":"35","author":[{"given":"Jordi","family":"Bruix","sequence":"first","affiliation":[]},{"given":"Morris","family":"Sherman","sequence":"additional","affiliation":[]},{"given":"Josep M","family":"Llovet","sequence":"additional","affiliation":[]},{"given":"Michel","family":"Beaugrand","sequence":"additional","affiliation":[]},{"given":"Riccardo","family":"Lencioni","sequence":"additional","affiliation":[]},{"given":"Andrew K","family":"Burroughs","sequence":"additional","affiliation":[]},{"given":"Erik","family":"Christensen","sequence":"additional","affiliation":[]},{"given":"Luigi","family":"Pagliaro","sequence":"additional","affiliation":[]},{"given":"Massimo","family":"Colombo","sequence":"additional","affiliation":[]},{"given":"Juan","family":"Rod\u00e9s","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0168-8278(01)00130-1_BIB1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2007-1007117","article-title":"Epidemiology of primary liver cancer","volume":"19","author":"Bosch","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199903113401001","article-title":"Rising incidence of hepatocellular carcinoma in the United States","volume":"340","author":"El Serag","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB3","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(85)91785-4","article-title":"Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients","volume":"1","author":"Zaman","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB4","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/hep.1840130516","article-title":"Independent risk factors for hepatocellular carcinoma in French drinkers","volume":"13","author":"Poynard","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM199109053251002","article-title":"Hepatocellular carcinoma in Italian patients with cirrhosis","volume":"325","author":"Colombo","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB6","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199306243282501","article-title":"Risk factors for hepatocellular carcinoma among patients with chronic liver disease","volume":"328","author":"Tsukuma","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/gut.48.2.251","article-title":"Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost-effectiveness analysis","volume":"48","author":"Bolondi","year":"2001","journal-title":"Gut"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0270-9139(95)90411-5","article-title":"Occurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis","volume":"21","author":"Fattovich","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/1097-0142(19880801)62:3<611::AID-CNCR2820620328>3.0.CO;2-0","article-title":"Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection and alcohol","volume":"62","author":"Villa","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB10","first-page":"2506","article-title":"Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in Southern Guangxi, China","volume":"49","author":"Yeh","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0016-5085(86)90919-4","article-title":"Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study","volume":"90","author":"Liaw","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB12","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(81)90585-7","article-title":"Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan","volume":"2","author":"Beasley","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB13","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1002\/hep.1840080628","article-title":"Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen\/antibody in serum: a prospective study","volume":"8","author":"Sakuma","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/hep.510250344","article-title":"Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study","volume":"25","author":"Bruno","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/hep.1840180109","article-title":"A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis","volume":"18","author":"Ikeda","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gut.47.1.131","article-title":"Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death","volume":"47","author":"Degos","year":"2000","journal-title":"Gut"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB17","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM198511143132004","article-title":"Survival and causes of death in cirrhotic and in non-cirrhotic patients with primary hemochromatosis","volume":"313","author":"Niederau","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB18","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/hep.1840200608","article-title":"Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis","volume":"20","author":"Fargion","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB19","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.510260508","article-title":"Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes","volume":"26","author":"Jones","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/oxfordjournals.aje.a010180","article-title":"Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan","volume":"151","author":"Mori","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0010-7824(97)00158-3","article-title":"Oral contraceptives and liver cancer. Results of the Multicentre International Liver Tumor Study","volume":"56","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/hep.1840190111","article-title":"Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma","volume":"19","author":"Oka","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB23","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJM199306243282502","article-title":"Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein","volume":"328","author":"Sato","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB24","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.1840220317","article-title":"A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients","volume":"22","author":"Shiraki","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.1840110321","article-title":"Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma","volume":"11","author":"Tsai","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB26","first-page":"703","article-title":"Macroregenerative nodules in a series of adult cirrhotic liver explants: issues of classification and nomenclature","volume":"21","author":"Hytiroglou","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB27","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/hep.510230527","article-title":"Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis","volume":"23","author":"Ganne-Carrie","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB28","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/0016-5085(95)90455-7","article-title":"Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study","volume":"108","author":"Borzio","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB29","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(97)08002-1","article-title":"Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection","volume":"351","author":"Shibata","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/mp.51.2.96","article-title":"Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis","volume":"51","author":"Borzio","year":"1998","journal-title":"Mol Pathol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00043426-199205000-00005","article-title":"Epidemiologic approach for cancer screening. Problems in design and analysis of trials","volume":"14","author":"Prorok","year":"1992","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0002-9343(96)00197-0","article-title":"Cost-effectiveness of screening for detection of small hepatocellular carcinoma in Western patients with Child-Pugh class A cirrhosis","volume":"101","author":"Sarasin","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.510270140","article-title":"Screening for hepatocellular carcinoma","volume":"27","author":"Collier","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB35","first-page":"45","article-title":"Growth kinetics of hepatocellular carcinoma","volume":"13","author":"Yoshino","year":"1983","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1148\/radiology.155.2.2984721","article-title":"Hepatocellular carcinoma in the early stage","volume":"155","author":"Sheu","year":"1985","journal-title":"Radiology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0016-5085(86)90923-6","article-title":"Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients","volume":"90","author":"Ebara","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB38","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/hep.1840160122","article-title":"Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival","volume":"16","author":"Barbara","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB39","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.1840060432","article-title":"Early recognition of hepatocellular carcinoma","volume":"6","author":"Okuda","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB40","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0168-8278(01)00025-3","article-title":"Alphafetoprotein: an obituary","volume":"34","author":"Sherman","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB41","series-title":"Hepatocellular carcinoma","author":"Nakashima","year":"1987"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB42","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0168-8278(96)80120-6","article-title":"Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma \u2013 a study based on 420 patients","volume":"25","author":"Huang","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB43","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1159\/000328523","article-title":"Accuracy of cytology vs. microbiopsy for the diagnosis of well-differentiated hepatocellular carcinoma and macroregenerative nodule. Definition of standardized criteria from a study of 100 cases","volume":"44","author":"Longchampt","year":"2000","journal-title":"Acta Cytol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB44","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/hep.510300411","article-title":"Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy","volume":"30","author":"Torzilli","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB45","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2214\/ajr.173.3.10470886","article-title":"Contrast enhancement of small hepatocellular carcinoma: usefulness of three successive early image acquisitions during multiphase dynamic MR imaging","volume":"173","author":"Yu","year":"1999","journal-title":"Am J Roentgenol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB46","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s002619900543","article-title":"Optimal phases of dynamic CT for detecting hepatocellular carcinoma: evaluation of unenhanced and triple-phase images","volume":"24","author":"Kim","year":"1999","journal-title":"Abdom Imaging"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB47","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2214\/ajr.175.3.1750693","article-title":"Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients","volume":"175","author":"Lim","year":"2000","journal-title":"Am J Roentgenol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB48","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1148\/radiology.215.3.r00jn03746","article-title":"Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT","volume":"215","author":"Nino-Murcia","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB49","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s002610000025","article-title":"Needle-tract implantation in hepatocellular carcinoma: frequency and CT findings after biopsy with a 19.5-gauge automated biopsy gun","volume":"25","author":"Kim","year":"2000","journal-title":"Abdom Imaging"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB50","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0016-5085(96)70021-5","article-title":"Adult cirrhotic liver explants: precancerous lesions and undetected small hepatocellular carcinomas","volume":"111","author":"Mion","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB51","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0168-8278(98)80324-3","article-title":"Diagnostic value and tolerance of Lipiodol-computed tomography for the detection of small hepatocellular carcinoma: correlation with pathologic examination of explanted livers","volume":"28","author":"Bizollon","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s002619900007","article-title":"Small hepatocellular carcinoma: differentiation from adenomatous hyperplasia with color Doppler US and dynamic Gd-DTPA-enhanced MR imaging","volume":"21","author":"Lencioni","year":"1996","journal-title":"Abdom Imaging"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB53","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1148\/radiology.216.1.r00jl24154","article-title":"Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis","volume":"216","author":"Ward","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB54","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB55","series-title":"TNM classification of malignant tumours: International Union Against Cancer (UICC)","first-page":"74","year":"1997"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB56","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W","article-title":"The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting","volume":"53","author":"Mor","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB57","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/bjc.1993.140","article-title":"Performance status assessment in cancer patients. An inter-observer variability study","volume":"67","author":"Sorensen","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB58","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E","article-title":"Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients","volume":"56","author":"Okuda","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB59","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hep.510280322","article-title":"A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients","volume":"28","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB60","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-8278(99)80173-1","article-title":"A new prognostic classification for predicting survival in patients with hepatocellular carcinoma","volume":"31","author":"Chevret","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB61","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB62","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.510290145","article-title":"Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials","volume":"29","author":"Llovet","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB63","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/jhep.2000.9603","article-title":"Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival","volume":"32","author":"Villa","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB64","series-title":"Liver malignancies. Diagnostic and interventional radiology","first-page":"467","article-title":"Imaging evaluation of tumor response","author":"Bartolozzi","year":"1999"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB65","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB66","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1053\/he.2000.6959","article-title":"Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy","volume":"31","author":"Llovet","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB67","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1002\/1097-0142(19941115)74:10<2772::AID-CNCR2820741006>3.0.CO;2-V","article-title":"Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan","volume":"74","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB68","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0168-8278(00)80427-4","article-title":"Hepatobiliary surgery","volume":"32","author":"Bismuth","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB69","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1053\/jhep.2000.20456","article-title":"Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan","volume":"32","author":"Arii","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB70","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0168-8278(00)80137-3","article-title":"Hepatocellular carcinoma and the art of prognostication","volume":"33","author":"Johnson","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB71","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/hep.510300629","article-title":"Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation","volume":"30","author":"Llovet","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB72","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/gut.42.6.883","article-title":"Limits to liver transplantation in the UK","volume":"42","author":"Pereira","year":"1998","journal-title":"Gut"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB73","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2007-1007120","article-title":"Liver transplantation for hepatocellular carcinoma","volume":"19","author":"Bismuth","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB74","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1527-6465(00)80028-3","article-title":"Right lobe living donor liver transplantation: a review","volume":"6","author":"Marcos","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB75","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB76","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-2000-13154","article-title":"Liver transplantation for hepatic and biliary malignancy","volume":"20","author":"Wall","year":"2000","journal-title":"Semin Liv Dis"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB77","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.510290122","article-title":"High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes","volume":"29","author":"Prieto","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB78","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0016-5085(99)70454-3","article-title":"European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group","volume":"117","author":"Feray","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB79","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1148\/radiology.161.2.3020612","article-title":"US-guided percutaneous alcohol injection of small hepatic and abdominal tumors","volume":"161","author":"Livraghi","year":"1986","journal-title":"Radiology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB80","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2214\/ajr.155.6.2173384","article-title":"Percutaneous ethanol injection therapy of hepatocellular carcinoma: analysis of 77 patients","volume":"155","author":"Shiina","year":"1990","journal-title":"Am J Roentgenol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB81","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1148\/radiology.197.1.7568806","article-title":"Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection","volume":"197","author":"Livraghi","year":"1995","journal-title":"Radiology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB82","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.1840160212","article-title":"Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma","volume":"16","author":"Vilana","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB83","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/(SICI)1097-0142(19960501)77:9<1792::AID-CNCR6>3.0.CO;2-E","article-title":"Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection","volume":"77","author":"Ishii","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB84","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0168-8278(97)80324-8","article-title":"Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients","volume":"27","author":"Castellano","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB85","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s003300050409","article-title":"Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long-term survival rate","volume":"8","author":"Lencioni","year":"1998","journal-title":"Eur Radiol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB86","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2214\/ajr.170.4.9530053","article-title":"Ablation of liver tumors using percutaneous RF therapy","volume":"170","author":"Goldberg","year":"1998","journal-title":"Am J Roentgenol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB87","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1053\/gast.1996.v110.pm8613057","article-title":"Microwave coagulation therapy for hepatocellular carcinoma","volume":"110","author":"Sato","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB88","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1268::AID-CNCR9>3.0.CO;2-B","article-title":"Cryosurgery as a treatment for advanced stage hepatocellular carcinoma: results, complications, and alcohol ablation","volume":"82","author":"Wong","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB89","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0929-8266(00)00086-0","article-title":"Interstitial laser photocoagulation under ultrasound guidance of liver tumors: results in 104 treated patients","volume":"11","author":"Giorgio","year":"2000","journal-title":"Eur J Ultrasound"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB90","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1148\/radiology.210.3.r99fe40655","article-title":"Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection","volume":"210","author":"Livraghi","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB91","first-page":"1121","article-title":"Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection","volume":"18","author":"Castells","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB92","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199606133342402","article-title":"Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma","volume":"334","author":"Muto","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB93","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(98)06475-7","article-title":"Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial","volume":"353","author":"Lau","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB94","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0140-6736(00)02654-4","article-title":"Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial","volume":"356","author":"Takayama","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB95","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1053\/jhep.2000.9409","article-title":"Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor. A prospective randomized study of hepatitis C virus-related liver cancer","volume":"32","author":"Ikeda","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB96","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/0168-8278(95)80445-5","article-title":"No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis","volume":"22","author":"Livraghi","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB97","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2214\/ajr.160.5.7682378","article-title":"Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients","volume":"160","author":"Shiina","year":"1993","journal-title":"Am J Roentgenol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB98","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s003300050194","article-title":"Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience","volume":"7","author":"Lencioni","year":"1997","journal-title":"Eur Radiol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB99","doi-asserted-by":"crossref","unstructured":"Llovet JM, Bruix J, Capurro S, Vilana R, for the BCLC Group. Long-term survival after ethanol injection for small hepatocellular carcinoma in 100 cirrhotic patients. Relevance of maintained success. J Hepatol 1999;30:100A.","DOI":"10.1002\/hep.510300629"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2036.1998.00286.x","article-title":"Review article: overview of medical treatments in unresectable hepatocellular carcinoma \u2013 an impossible meta-analysis?","volume":"12","author":"Mathurin","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB101","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/A:1008285123736","article-title":"Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials","volume":"8","author":"Simonetti","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB102","first-page":"1782","article-title":"Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support","volume":"35","author":"Raoul","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB103","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/gut.42.3.442","article-title":"Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study","volume":"42","author":"Kouroumalis","year":"1998","journal-title":"Gut"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB104","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0016-5085(88)90436-2","article-title":"Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma \u2013 a randomized controlled trial","volume":"94","author":"Lin","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB105","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0168-8278(90)90110-D","article-title":"A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma","volume":"11","author":"Pelletier","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB106","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1136\/gut.34.11.1598","article-title":"Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma","volume":"34","author":"Madden","year":"1993","journal-title":"Gut"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB107","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM199505113321903","article-title":"A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma","volume":"332","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB108","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/hep.510270617","article-title":"Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution","volume":"27","author":"Bruix","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB109","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0168-8278(98)80187-6","article-title":"Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial","volume":"29","author":"Pelletier","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0168-8278(90)90211-9","article-title":"Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen","volume":"11","author":"Farinati","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB111","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0168-8278(05)80138-2","article-title":"Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma","volume":"20","author":"Martinez Cerezo","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB112","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0016-5085(95)90402-6","article-title":"Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients","volume":"109","author":"Castells","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB113","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0140-6736(98)01259-8","article-title":"Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB114","first-page":"1535","article-title":"Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: a randomized, controlled trial","volume":"21","author":"Manesis","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB115","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1200\/JCO.1998.16.2.411","article-title":"Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial","volume":"16","author":"Grimaldi","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB116","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/hep.1840170307","article-title":"Recombinant interferon-alpha in inoperable hepatocellular carcinoma: a randomized controlled trial","volume":"17","author":"Lai","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.510310111","article-title":"Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma","volume":"31","author":"Llovet","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0305-7372(88)90007-2","article-title":"Clinical trials in primary hepatocellular carcinoma: current status and future directions","volume":"15","author":"Nerenstone","year":"1988","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB119","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/hep.1840160119","article-title":"Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy","volume":"16","author":"Okada","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0168-8278(91)90873-A","article-title":"Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodol","volume":"13","author":"Johnson","year":"1991","journal-title":"J Hepatol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB121","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","article-title":"Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children","volume":"336","author":"Chang","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB122","first-page":"127","article-title":"Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers","volume":"7","author":"Kensler","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Suppl 1","key":"10.1016\/S0168-8278(01)00130-1_BIB123","first-page":"3","article-title":"International Consensus Conference on Hepatitis C. Consensus statement","volume":"31","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB124","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-129-2-199807150-00005","article-title":"Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C","volume":"129","author":"Imai","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB125","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0140-6736(95)91739-X","article-title":"Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis","volume":"346","author":"Nishiguchi","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB126","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/hep.510290616","article-title":"Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatment","volume":"29","author":"Valla","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB127","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(00)03595-9","article-title":"Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis","volume":"357","author":"Nishiguchi","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/S0168-8278(01)00130-1_BIB128","doi-asserted-by":"crossref","first-page":"696","DOI":"10.7326\/0003-4819-131-9-199911020-00011","article-title":"Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis B or hepatitis C virus infection","volume":"131","author":"Baffis","year":"1999","journal-title":"Ann Intern Med"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827801001301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827801001301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T16:18:53Z","timestamp":1580228333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827801001301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":128,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["S0168827801001301"],"URL":"https:\/\/doi.org\/10.1016\/s0168-8278(01)00130-1","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}